Thrombopoietic agent
Thrombopoietic agents are drugs that induce the growth and maturation of megakaryocytes. Two of them are currently in clinical use: interleukin 11 and thrombopoietin. Several others are under clinical investigation.
References
- Michael Clinton Perry. The Chemotherapy Source Book. Lippincott Williams & Wilkins, 2008 pg. 51
|
---|
Chemokine | |
---|
CSF | |
---|
Interferon | IFNAR (α/β, I) |
- Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
- Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
- Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
- Decoy receptors: Bifarcept
|
---|
IFNGR (γ, II) | |
---|
IFNLR (λ, III) |
- See IL-28R (IFNLR) here instead.
|
---|
|
---|
Interleukin | |
---|
TGFβ | |
---|
TNF | |
---|
Others | |
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Growth factor receptor modulators
|